Cox, M., Yang, C.-F., Speicher, P., Fitch, Z., Gu, L., Davis, R., … Berry, M. (2017). P3.04-013 The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma. In Journal of Thoracic Oncology (Vol. 12, pp. S1391–S1392). Elsevier BV. https://doi.org/10.1016/j.jtho.2016.11.2128

Cox, Morgan, Chi-Fu Yang, Paul Speicher, Zachary Fitch, Lin Gu, Robert Davis, Thomas D’Amico, Matthew Hartwig, David Harpole, and Mark Berry. “P3.04-013 The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma.” In Journal of Thoracic Oncology, 12:S1391–92. Elsevier BV, 2017. https://doi.org/10.1016/j.jtho.2016.11.2128.

Cox M, Yang C-F, Speicher P, Fitch Z, Gu L, Davis R, et al. P3.04-013 The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma. In: Journal of Thoracic Oncology. Elsevier BV; 2017. p. S1391–2.

Cox, Morgan, et al. “P3.04-013 The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma.” Journal of Thoracic Oncology, vol. 12, no. 1, Elsevier BV, 2017, pp. S1391–92. Crossref, doi:10.1016/j.jtho.2016.11.2128.

Cox M, Yang C-F, Speicher P, Fitch Z, Gu L, Davis R, D’Amico T, Hartwig M, Harpole D, Berry M. P3.04-013 The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma. Journal of Thoracic Oncology. Elsevier BV; 2017. p. S1391–S1392.